Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 340

1.

Comparison of screening methods in the detection of bladder cancer.

Ramakumar S, Bhuiyan J, Besse JA, Roberts SG, Wollan PC, Blute ML, O'Kane DJ.

J Urol. 1999 Feb;161(2):388-94.

PMID:
9915409
2.

A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.

Halling KC, King W, Sokolova IA, Karnes RJ, Meyer RG, Powell EL, Sebo TJ, Cheville JC, Clayton AC, Krajnik KL, Ebert TA, Nelson RE, Burkhardt HM, Ramakumar S, Stewart CS, Pankratz VS, Lieber MM, Blute ML, Zincke H, Seelig SA, Jenkins RB, O'Kane DJ.

J Urol. 2002 May;167(5):2001-6.

PMID:
11956427
4.

Current bladder tumor tests: does their projected utility fulfill clinical necessity?

Lokeshwar VB, Soloway MS.

J Urol. 2001 Apr;165(4):1067-77. Review.

PMID:
11257640
5.

Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors.

Giannopoulos A, Manousakas T, Gounari A, Constantinides C, Choremi-Papadopoulou H, Dimopoulos C.

J Urol. 2001 Aug;166(2):470-5.

PMID:
11458049
7.

Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer?

Wiener HG, Mian C, Haitel A, Pycha A, Schatzl G, Marberger M.

J Urol. 1998 Jun;159(6):1876-80.

PMID:
9598479
8.

Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer.

Landman J, Chang Y, Kavaler E, Droller MJ, Liu BC.

Urology. 1998 Sep;52(3):398-402.

PMID:
9730450
9.

Human complement factor H related protein test for monitoring bladder cancer.

Raitanen MP, Marttila T, Nurmi M, Ala-Opas M, Nieminen P, Aine R, Tammela TL; Finnbladder Group.

J Urol. 2001 Feb;165(2):374-7.

PMID:
11176376
10.
11.

Rapid detection of bladder cancer: a comparative study of point of care tests.

Johnston B, Morales A, Emerson L, Lundie M.

J Urol. 1997 Dec;158(6):2098-101.

PMID:
9366321
12.

A study comparing various noninvasive methods of detecting bladder cancer in urine.

Saad A, Hanbury DC, McNicholas TA, Boustead GB, Morgan S, Woodman AC.

BJU Int. 2002 Mar;89(4):369-73.

13.

Comparative study of NMP-22, telomerase, and BTA in the detection of bladder cancer.

Abd El Gawad IA, Moussa HS, Nasr MI, El Gemae EH, Masooud AM, Ibrahim IK, El Hifnawy NM.

J Egypt Natl Canc Inst. 2005 Sep;17(3):193-202.

14.

Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.

Kumar A, Kumar R, Gupta NP.

Jpn J Clin Oncol. 2006 Mar;36(3):172-5. Epub 2006 Mar 6.

16.
17.
18.

Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.

Raitanen MP, Leppilahti M, Tuhkanen K, Forssel T, Nylund P, Tammela T; FinnBladder Group.

Ann Chir Gynaecol. 2001;90(4):261-5.

PMID:
11820414
19.

Urine cytology. It is still the gold standard for screening?

Brown FM.

Urol Clin North Am. 2000 Feb;27(1):25-37. Review.

PMID:
10696242
20.

A side by side comparison of cytology and biomarkers for bladder cancer detection.

Schroeder GL, Lorenzo-Gomez MF, Hautmann SH, Friedrich MG, Ekici S, Huland H, Lokeshwar V.

J Urol. 2004 Sep;172(3):1123-6.

PMID:
15311054
Items per page

Supplemental Content

Write to the Help Desk